For the Quarter Ending March 2025
North America
In the first quarter of 2025 the Monocalcium Phosphate (Monohydrate) prices in North America saw a healthy rise of 5.94% on average. The increase was supported by strong demand from the pharmaceutical and food sectors. The production activity gradually picked up with the seasonal shift from winter to early spring. Several buyers across the region planned procurement in advance in anticipation of better demand in the coming quarter. This led to firm price levels in the entire North American region in the first quarter of 2025.
Tariff regulations remained in place but did not sharply affect the overall trade and prices. The supply situation stayed balanced as producers managed inventories well. Logistics also ran smoothly which allowed consistent movement of goods. Demand from downstream sectors like food processing and nutraceuticals improved as companies prepared for post-winter sales cycles.
Procurement was steady and most buyers restocked to ensure readiness for upcoming consumption. The positive demand and organized supply helped prices move upward in the region. Overall, the North American market remained active and optimistic with a clear upward trend in pricing throughout the quarter.
Asia Pacific
In Asia Pacific, the market for Monocalcium Phosphate (Monohydrate) recorded a modest average price increase of 0.12% during the first quarter of 2025 in comparison to the previous quarter. The region remained generally stable which was supported by seasonal changes and early-year adjustments. The Chinese Lunar New Year, which fell in the early part of the quarter had a slight impact and slowed production activity for a brief period. However, after the holiday, production resumed steadily and helped meet regular demand.
The seasonal transition played a quiet role in supporting production and consumption across the region. Procurement from downstream sectors such as food and beverages remained consistent. While the price rise was not sharp, it reflected balanced market behaviour. Inventories were handled with care and there was no major oversupply. Supply chains operated efficiently in most areas across APAC region. Even though the increase was small, it suggested that overall demand held firm.
The market moved gradually and was driven by practical procurement, regular offtakes and anticipation of the upcoming production cycle. The soft price movement reflected a stable outlook without large fluctuations across the Asia Pacific region during first quarter of 2025.
Europe
In European region the Monocalcium Phosphate (Monohydrate) prices rose by an average of 3.07% during the first quarter of 2025 compared the average prices in previous quarter. The European market remained stable and well-aligned with regional demand. Pharmaceutical and food industries showed improved activity as warmer temperatures arrived which observed increase of demand from end-user sector.
The seasonal shift encouraged higher production which helped to support regular procurement throughout the quarter. Buyers acted early to secure stock in the first quarter in anticipation of stronger usage in the upcoming period and aligned their inventories beforehand. This helped to keep prices elevated in the European region.
Suppliers ensured smooth deliveries, and inventories were well managed. There were no major supply chain hurdles during this period. Downstream demand stayed strong and procurement was paced to meet upcoming needs. The overall market sentiment in Europe remained positive. The steady rise in prices reflected healthy demand conditions and strong logistical support. The upward trend appeared gradual and driven by logical buying behaviour, aligning with improved activity in core application sectors like food and nutraceuticals.
For the Quarter Ending December 2024
North America
The U.S. Monocalcium Phosphate Market in Q4 2024 showcase a Volatile Quarter with a Downward Trend. The fourth quarter of 2024 saw a mixed yet overall downward pricing trend in the U.S. Monocalcium Phosphate market. October witnessed a sharp price surge due to heightened seasonal demand from food and beverage sectors, elevated shipping costs from Asian suppliers, supply chain constraints, and rising raw material prices. Strategic stockpiling and global disruptions in Ukraine and the Middle East compounded supply-side pressures, keeping prices high.
However, in November, prices declined significantly as reduced domestic inventories and lower export prices created arbitrage opportunities. Competitive pricing strategies for the holiday season, coupled with record cargo processing, further eased prices. Demand remained cautious, driven by cost-conscious purchasing rather than strong consumption.
December continued the downward trend, marked by weak demand from pharmaceuticals and oversupply due to elevated inventories and aggressive destocking efforts. Intense competition from Chinese imports added pressure, while new orders fell amid policy uncertainty. Despite the challenges, manufacturers increased employment but scaled back purchasing activity, reflecting subdued market sentiment.
Asia Pacific
Monocalcium Phosphate prices exhibited volatility in Q4 2024, with an overall downward trajectory following an initial surge in October.
In October, prices rose sharply in China due to logistical disruptions caused by severe typhoons, heightened procurement ahead of seasonal demand, and increased pharmaceutical sector consumption. Tight raw material supply, particularly Phosphoric Acid, added to the price pressure, with low inventories and robust buying activity amplifying the upward trend. However, China's economy showed early signs of recovery, with the manufacturing PMI rising to 50.1, though challenges like export declines and rising input costs persisted.
In November, prices declined as producers aggressively reduced inventory ahead of the holiday season, despite steady demand. Oversupply, weak downstream absorption, and geopolitical pressures, such as tariff uncertainties, exacerbated the decline, creating a buyer's market.
Overall, Q4 demonstrated a mixed trend—initial price increases followed by market corrections—driven by structural market conditions, seasonal dynamics, and external factors. The supply-demand imbalance is likely to persist until significant production cuts or demand improvements materialize.
Europe
The Monocalcium Phosphate market in Germany experienced a mixed trend in Q4 2024, starting with a steady price rise but ending with pronounced price declines. In early Q4 2024, Monocalcium Phosphate prices in Germany rose steadily due to constrained supply from key producers, elevated input costs, and strategic price hikes by domestic participants.
Divergent downstream demand, particularly in the pain relief industry, and tight phosphoric acid availability further amplified the bullish sentiment. However, November marked a significant shift as prices entered a downward trajectory due to subdued demand, reduced production costs, and persistent oversupply across the European market. Favorable production conditions, high inventory levels, and competitive buying opportunities pressured prices downward, prompting manufacturers to cut prices aggressively to manage inventories.
Weak downstream demand, cautious procurement, and Euro depreciation sustained the bearish sentiment throughout December. Surplus supply conditions, driven by pre-holiday stockpiling and favorable import dynamics, compounded the softening price trend. Overall, Q4 ended with bearish momentum as suppliers focused on inventory normalization rather than shifts in demand, delaying any prospects for price recovery.
For the Quarter Ending September 2024
North America
In Q3 2024, the North American Monocalcium Phosphate market experienced a consistent decline in prices, especially in the USA. Several factors contributed to this downward trend, primarily an abundant supply combined with weak demand on both domestic and international fronts. Consumption in downstream industries remained subdued, further disrupting the supply-demand balance. Reduced trading activity and lackluster demand from neighboring regions also played significant roles in the price decrease.
Additionally, a decline in raw material demand prompted manufacturers to cut back on production, marking the first contraction in supplier lead times in three months. End-users adopted a cautious purchasing strategy, focusing solely on essential needs, which dampened overall buying interest and perpetuated the negative market sentiment.
Throughout the quarter, the market outlook remained weak, reflecting persistent oversupply conditions and sluggish demand. The first half of the quarter saw a more pronounced price decrease compared to the latter half, concluding at USD 1490/MT CFR New York. The average quarterly decline was 0.16%, indicating a sustained downward pricing trend. Notably, there were no disruptions or plant shutdowns reported during this period.
Asia Pacific
In Q3 2024, the Monocalcium Phosphate market in the APAC region saw a steady price increase driven by multiple factors. Strong demand and limited supply, compounded by logistical challenges, created a favorable pricing environment. Increased industrial activity and robust international demand led to supply chain disruptions and cargo shortages, further straining supply. Ongoing plant maintenance and reduced inventory levels also contributed to the upward price trend.
China emerged as a significant player in the market, experiencing the most pronounced price fluctuations. The quarter exhibited a clear seasonal trend, with prices steadily rising compared to the same period last year. The market demonstrated a quarter-on-quarter increase of 9%, highlighting its positive momentum. By the end of Q3 2024, the price of Monocalcium Phosphate (Monohydrate) FOB Shanghai in China reached USD 1430/MT, marking an average quarterly increase of 2.45%.
This combination of strong demand, constrained supply, and logistical challenges underscores the dynamic nature of the Monocalcium Phosphate market in the region, positioning it for continued growth as industrial activities expand and international demand remains robust.
Europe
In Q3 2024, Monocalcium Phosphate prices in Europe, particularly in Germany, saw a notable decline. This trend was influenced by several factors, including reduced production costs stemming from lower energy expenses. The market also faced oversupply challenges due to weakened demand in various end-use sectors.
To manage storage costs and prevent product degradation, companies resorted to offloading excess inventories, further intensifying the supply glut. Traders were compelled to liquidate holdings to stabilize cash flow amid weak sales. Although the Euro appreciated against the USD, purchasing sentiment remained subdued, especially in southern Europe. Germany, as a major importer, was significantly impacted by these global and local factors, leading to a persistent decrease in Monocalcium Phosphate prices.
Throughout the quarter, a consistent downward trend was observed, particularly in August. The market is expected to remain under pressure until a substantial change occurs in supply or demand dynamics. By the end of Q3 2024, the price of Monocalcium Phosphate (Monohydrate) CFR Hamburg in China reached USD 1476/MT, reflecting a slight average quarterly increase of 0.75%.
For the Quarter Ending June 2024
North America
In Q2 2024, the North American market for Monocalcium Phosphate witnessed a notable surge in prices, driven by several complex factors. Global supply chain disruptions, such as the drought affecting the Panama Canal and militant activities in the Red Sea, have significantly increased shipping costs and reduced vessel availability. Geopolitical tensions and economic uncertainties have further exacerbated logistical challenges, leading to higher freight charges. As a major importer, the U.S. faced substantial impacts from these disruptions, which amplified the cost dynamics for Monocalcium Phosphate.
In the United States, the pricing environment has been particularly volatile, influenced by both rising demand and restricted supply. The early onset of the peak shipping season and concerns over potential labor disputes at U.S. ports have heightened market pressures. Despite an overall improvement in market sentiment, the U.S. manufacturing sector's continued contraction influenced purchasing behaviors. The depreciation of the U.S. dollar added another layer of complexity, making imports more expensive and driving domestic prices higher. Consequently, the quarter ended with an 8% price increase from the first to the second half, reaching USD 1500/MT CFR New York for Monocalcium Phosphate (Monohydrate).
Overall, Q2 2024 has been marked by a challenging yet positive pricing environment for Monocalcium Phosphate. Prices have increased steadily due to strong demand and ongoing supply chain disruptions. The average quarterly incline of 0.98% reflects the persistent upward pressure on prices, underscoring the need for strategic planning and adaptability in navigating these market conditions.
Asia Pacific
In Q2 2024, the APAC region saw a significant rise in Monocalcium Phosphate prices, influenced by a mix of strategic and economic factors. Robust demand from downstream industries remained high throughout the quarter, driving prices up. Additionally, escalating raw material costs, particularly Phosphoric Acid, further increased production expenses. Seasonal factors, such as peak agricultural activity, also heightened demand for Monocalcium Phosphate as a key fertilizer component. Supply chain disruptions due to periodic plant maintenance shutdowns exacerbated the supply tightness, pushing prices even higher.
In China, where price changes were most pronounced, market dynamics were particularly striking. The appreciation of the Chinese yuan against the US dollar incentivized exports, tightening domestic supply. Chinese manufacturers took advantage of favorable exchange rates, intensifying competition and driving prices up. The overall sentiment remained positive, with stable demand bolstered by strong agricultural sector performance. Price trends exhibited notable seasonality, with increased demand during the planting season correlating with higher prices. The quarter recorded a 6% price increase from the first to the second half, reflecting the persistent upward momentum and a generally positive pricing trajectory despite challenges.
The quarter concluded with Monocalcium Phosphate (Monohydrate) FOB Shanghai prices settling at USD 1330/MT, with an average quarterly inclination of 1.44%. This emphasizes the sustained upward trend driven by both domestic and international market forces. The overall environment was marked by cautious optimism, indicating that while there were challenges, the market conditions supported a generally positive pricing outlook for Monocalcium Phosphate.
Europe
The second quarter of 2024 has seen a steady increase in Monocalcium Phosphate prices throughout the Europe region. This escalation is driven by rising production costs in key manufacturing areas and heightened demand from downstream sectors. Logistical disruptions, such as the Panama Canal drought and shipping delays around the Cape of Good Hope, have exacerbated supply chain issues, contributing to the supply-demand imbalance. Geopolitical instability, particularly the Houthis' campaign against Israel in Gaza, has further strained logistics and increased shipping costs. Additionally, the depreciation of the US dollar has complicated import dynamics, pushing costs higher for European buyers.
Germany experienced the most pronounced price changes during this period. The nation faced severe supply constraints due to limited inventories from exporting countries, compounded by domestic inflationary pressures that exceeded forecasts. The German inflation rate notably impacted the overall cost of goods, reflecting a more inflationary cycle. Seasonal demand fluctuations further intensified procurement activities, with businesses raising prices to leverage arbitrage opportunities.
By the end of the quarter, the price of Monocalcium Phosphate (Monohydrate) CFR Hamburg in Germany settled at USD 1445/MT, with an average quarterly increase of 1.12%. This marks a substantial recovery in market sentiment, indicating a positive pricing environment. The combination of supply constraints, logistical disruptions, and inflationary pressures has significantly influenced the market dynamics, leading to a notable rise in prices across the region.
